@article{1482856,
      recid = {1482856},
      author = {Patravale, Vandana. and Date, Abhijit A. and Jindal, Anil  B.},
      title = {Nanomedicines for the prevention and treatment of  infectious diseases /},
      publisher = {Springer,},
      address = {Cham :},
      pages = {1 online resource (415 p.).},
      year = {2023},
      note = {12 Challenges Encountered by Nanomedicines Before Entering  the Lungs Are},
      abstract = {The COVID-19 pandemic has altered the world and reiterated  the perpetual need for the development of effective  strategies for the prevention and treatment of infectious  diseases. While globally prevalent infectious diseases  receive extensive attention in terms of drug development  and delivery, the neglected and/or emerging infectious  diseases that affect developing countries are often  overlooked. From the commercialization of AmBisome to the  emergency authorization of mRNA-based vaccines,  nanotechnology has played a vital role in the prevention  and treatment of infectious diseases. More importantly,  nanotechnology has enabled the effective utilization of  existing armamentarium against infectious diseases leading  to improved therapeutic outcomes with a concomitant  reduction in the side effects associated with  anti-infective agents. In particular, nanotechnology can  bring about a paradigm shift in the management of neglected  and emerging infectious diseases and may compensate for the  lack of drug discovery efforts. This book addresses an  unmet need in pharmaceutical and medical education. This  book provides a comprehensive and up-to-date overview of  the latest advancements in nanomedicine, which show great  potential for preventing and treating infectious diseases.  Covering a wide range of topics, it explores various  formulation strategies for combating microbial, fungal,  parasitic, and viral infections. The book emphasizes the  advantages of nano-scale vaccines over traditional ones and  discusses their production. It also examines feasible  treatment approaches for diseases like malaria,  trypanosomiasis, candidiasis, Hepatitis B, HIV, and the  ongoing COVID-19 pandemic. Additionally, it highlights the  role of nano-adjuvants in vaccine development, as well as  the use of peptide antibiotics and pulmonary delivery of  drugs, which open up new possibilities in fighting  infectious diseases. Furthermore, the book explores the  critical role of nanomedicine in addressing veterinary  parasitic infections. The emergence of nanotechnology has  led to novel strategies for diagnosing, treating, and  preventing parasitic infections in animals.},
      url = {http://library.usi.edu/record/1482856},
      doi = {https://doi.org/10.1007/978-3-031-39020-3},
}